Page results
-
Arif Ahmed is an entrepreneur and private equity investor in healthcare, technology, e-commerce and B2B services companies. He has a proven track record of scaling innovation in complex regulatory environments.
-
UCLH has recruited the first patient to a global study of a new drug in early development, called NI0752, which is thought to reduce the production of a protein in the brain called tau.
-
This information is for patients receiving steroids for immunotherapy toxicity.
-
This page is for cancer patients receiving immunotherapy treatment.
-
Researchers at UCLH and UCL have completed the first and only randomised trial to explore a new approach to treating aggressive lung cancer.
-
A new surgical technique could remove the risk of urinary incontinence after surgery to remove the prostate for men with prostate cancer.
-
A UCLH rheumatology team is leading an exciting project to help understand the reasons for young people missing their hospital appointments and find ways to improve this.
-
This page explains what sperm banking is, how it works and how it can benefit you.
-
This series of wellbeing videos have been designed to help people manage the side effects of cancer treatment.
-
This easy read page offers advice for patients on managing pain after an operation.
File results
-
FOI/2022/0276 - Biologic medicines within dermatology
-
FOI/2022/0278 - Surgical tables in use at Trust
-
FOI/2022/0280 - Applications or tools to communicate digitally with patients
-
FOI/2022/0282 - Decontamination and infection control leads; risk assessment group meetings
-
FOI/2022/0283 - Enhanced disinfection methods to eliminate HAIs in theatres, clinical areas and wards
-
FOI/2022/0285 - Paediatric audiology
-
FOI/2022/0286 - Fat-shaming complaints
-
FOI/2022/0287 - Device related delays in delivery of medication/ enteral feeding
-
FOI/2022/0288 - Patient deaths awaiting discharge as inpatient
-
FOI/2022/0293 - Patients treated with Ponvory, Tysabri, Vumerity, Zeposia